Chime Financial, Inc. Class A Common Stock
CHYM
$33.41
+5.53%
Chime Financial, Inc. is a financial technology company that provides digital banking services through its proprietary platform in partnership with third-party banks, offering spending accounts, credit-building tools, savings products, and community-focused financial services. As a leading neobank in the U.S., Chime distinguishes itself with a member-centric, fee-free model that has attracted millions of users, positioning it as a disruptive force in the regional banking sector. The current investor narrative centers on the company's recent transition to profitability, strong revenue growth, and the successful public listing in June 2025, with attention focused on its ability to sustain growth, expand margins, and navigate regulatory scrutiny in the evolving fintech landscape.…
CHYM
Chime Financial, Inc. Class A Common Stock
$33.41
Investment Opinion: Should I buy CHYM Today?
Based on the analysis, I rate CHYM as a Hold. The consensus is a Buy with an average target of $34.80, implying modest upside of 4.8% from the current price. The thesis is that Chime's strong growth and recent profitability justify the premium valuation, but the risk-reward is balanced given the wide target range and high uncertainty. Key supporting data points include: revenue growth of 24.8% YoY, forward PE of 20.6x, gross margin of 87.8%, and positive EPS of $0.14 in Q1 2026. However, the stock trades at a PS ratio of 4.36x, which is high for a bank, and the PEG ratio is negative, indicating that growth expectations are already embedded.
Sign up to view all
CHYM 12-Month Price Forecast
The AI assessment is neutral, reflecting a balanced risk-reward. Chime's growth and profitability are positive, but the valuation is not cheap, and the wide analyst target range indicates uncertainty. The stock could outperform if growth accelerates, but the risk of a pullback is elevated after the recent surge. I would upgrade to bullish if revenue growth exceeds 25% and the company raises guidance, and downgrade to bearish if growth falls below 15% or regulatory issues emerge.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Chime Financial, Inc. Class A Common Stock's 12-month outlook, with a consensus price target around $35.05 and implied upside of +4.9% versus the current price.
Average Target
$35.05
0 analysts
Implied Upside
+4.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$22 - $45
Analyst target range
The target price range spans from $22.00 (low) to $45.00 (high), with the high target suggesting potential for significant upside if the company accelerates growth and expands margins, while the low target reflects risks such as increased competition or regulatory challenges. The wide spread of $23.00 indicates high uncertainty, but recent upgrades from firms like Compass Point (from Neutral to Buy) and Goldman Sachs (from Neutral to Buy) suggest improving sentiment. The consensus implies a modest 4.8% upside, but the high target offers 35.5% upside, while the low target implies a 33.7% downside, highlighting the speculative nature of the stock.
Bulls vs Bears: CHYM Investment Factors
Chime presents a compelling growth story with accelerating revenue, a return to profitability, and strong analyst support. However, the stock's valuation is demanding, and the wide analyst target range reflects significant uncertainty. The bull case is currently stronger, driven by the company's fundamental turnaround and momentum, but the key tension is whether the market's growth expectations are sustainable. If Chime can maintain 20%+ revenue growth and expand margins, the stock could re-rate higher; if growth slows or regulatory issues emerge, the downside to the low target is substantial.
Bullish
- Revenue growth accelerating to 24.8% YoY: Q1 2026 revenue of $647.4M grew 24.8% YoY, up from $518.7M in Q1 2025, with sequential growth from $596.4M in Q4 2025. This acceleration indicates strong member adoption and transaction volumes, driving top-line momentum.
- Return to profitability with positive EPS: Q1 2026 net income was $53.5M (EPS $0.14), a sharp turnaround from the -$923M loss in Q2 2025 (which included one-time IPO-related charges). The positive net margin of 8.3% demonstrates the scalability of the fee-free model.
- Strong gross margin of 87.8%: Gross margin remained high at 87.8% in Q1 2026, consistent with prior quarters (88.9% in Q4 2025). This reflects the low-cost digital infrastructure and high incremental profitability on each additional member.
- Analyst upgrades and Buy consensus: Recent upgrades from Compass Point and Goldman Sachs (both from Neutral to Buy) have lifted sentiment. The consensus recommendation is 'Buy' with a mean score of 1.55, and the average target price of $34.80 implies ~4.8% upside from the current $33.20.
Bearish
- High valuation with forward PE of 20.6x: The forward PE of 20.62x is elevated for a regional bank, especially given the company's short history of profitability. The trailing PE is -9.43x due to past losses, and the PEG ratio is negative, suggesting the market is pricing in aggressive future growth.
- Wide analyst target range signals uncertainty: Analyst targets range from $22.00 (low) to $45.00 (high), a spread of $23.00. The low target implies a 33.7% downside from the current price, highlighting the speculative nature and high uncertainty in the stock's fair value.
- Dependence on continued growth to justify valuation: With a PS ratio of 4.36x and EV/Sales of 4.74x, the stock trades at a premium to traditional banks. If revenue growth decelerates below the current 24.8% pace, the multiple could compress, leading to significant downside.
- Regulatory and competitive risks in fintech: As a neobank, Chime faces regulatory scrutiny and intense competition from both traditional banks and other fintechs. Any adverse regulatory change or competitive pressure could impact its fee-free model and member growth.
CHYM Technical Analysis
Chime's stock has exhibited a robust uptrend over the past year, with a 1-year price change of +24.95%, significantly outperforming the S&P 500's +18.56% over the same period. The current price of $33.20 sits near the upper end of its 52-week range, at approximately 97.2% of the high of $34.16, indicating strong momentum and investor confidence. This positioning near the highs suggests the stock is in a bullish phase, though it also raises the risk of short-term overextension.
Beta
—
—
Max Drawdown
-52.2%
Largest decline past year
52-Week Range
$16-$34
Price range past year
Annual Return
+35.2%
Cumulative gain past year
| Period | CHYM Return | S&P 500 |
|---|---|---|
| 1m | +37.7% | +1.0% |
| 3m | +84.0% | +1.1% |
| 6m | +50.3% | +13.8% |
| 1y | +35.2% | +19.5% |
| ytd | +26.6% | +12.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CHYM Fundamental Analysis
Chime's revenue trajectory is accelerating, with the most recent quarter (Q1 2026) reporting revenue of $647.4 million, a 24.8% year-over-year increase, up from $518.7 million in Q1 2025. This growth is driven by strong performance in payments revenue, which totaled $432.6 million, and reflects the company's expanding member base and transaction volumes. The multi-quarter trend shows consistent sequential growth, with revenue rising from $475.2 million in Q4 2024 to $596.4 million in Q4 2025, indicating a healthy growth trajectory.
Quarterly Revenue
$647387000.0B
2026-03
Revenue YoY Growth
+24.8%
YoY Comparison
Gross Margin
87.8%
Latest Quarter
Free Cash Flow
$143518000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CHYM Overvalued?
Given Chime's positive net income of $53.5 million in Q1 2026, the PE ratio is the primary valuation metric. The trailing PE is -9.43x due to historical losses, but the forward PE is 20.62x, implying the market expects sustained profitability. The gap between trailing and forward PE reflects the market's anticipation of continued earnings growth, with analysts estimating EPS of $3.14 for the next fiscal year.
PE
-9.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 33x~46x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-9.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financially, Chime's primary risk is its reliance on continued revenue growth to justify its valuation. The company's net margin turned positive at 8.3% in Q1 2026, but this is a recent development; the trailing twelve-month net margin is still -46.2% due to the large loss in Q2 2025. The company has a low debt-to-equity ratio of 0.096, providing financial flexibility, but its price-to-cash-flow ratio of 180.6x indicates that free cash flow generation is still nascent. If growth decelerates, the high fixed costs in R&D and marketing could pressure margins, leading to earnings misses.
FAQ
The key risks are: 1) Valuation risk - the stock trades at a premium multiple, and if growth slows, the multiple could contract, leading to a significant downside (low target $22 implies -33.7%). 2) Regulatory risk - as a fintech, Chime faces regulatory scrutiny that could increase costs or restrict its business model. 3) Competitive risk - traditional banks and other neobanks are competing for the same customers, which could pressure member growth and revenue. 4) Financial risk - the company has a short history of profitability, and any reversal could impact investor confidence. The most severe risk is a combination of growth deceleration and regulatory headwinds, which could drive the stock to the low target.
The 12-month forecast is mixed, with a base case target of $34.80 (45% probability), a bull case target of $45 (30% probability), and a bear case target of $22 (25% probability). The base case assumes continued growth at a moderating pace, while the bull case requires sustained 25%+ growth and positive catalysts. The bear case would materialize if growth decelerates sharply or regulatory issues arise. The most likely scenario is the base case, with the stock trading near the average analyst target. Investors should monitor quarterly earnings for revenue growth and margin trends to gauge which scenario is unfolding.
CHYM is trading at a forward PE of 20.6x, which is not excessive for a company with 24.8% revenue growth, but the trailing PE is negative due to past losses. The PS ratio of 4.36x is high compared to traditional banks, but reasonable for a high-growth fintech. The stock is trading near its 52-week high, and the average analyst target implies only 4.8% upside, suggesting it is fairly valued. The market is pricing in continued strong growth and profitability, and any disappointment could lead to multiple compression. Relative to its own history, the stock has re-rated significantly since its IPO, and the current valuation leaves little room for error.
CHYM is a good buy for growth-oriented investors who believe in the neobank trend and can tolerate volatility. The stock has strong momentum, with a 1-year return of +24.95% and a recent surge of 78.5% in 3 months. However, the forward PE of 20.6x and the wide analyst target range (low $22, high $45) indicate significant uncertainty. The consensus is a Buy, but the average target price of $34.80 offers only 4.8% upside, suggesting the stock is fairly valued at current levels. A better entry point might be on a pullback toward the $30 level or below.
CHYM is more suitable for long-term investment, given its growth stage and volatility. The stock has a beta that is likely high, as evidenced by its 1-month relative strength of +42.6% and a max drawdown of -54.6% over the past year. Short-term trading could be profitable but is risky due to the recent surge and potential for pullbacks. For long-term investors, the company's revenue growth and path to profitability are positive, but they should be prepared for volatility. A minimum holding period of 3-5 years is recommended to allow the growth story to play out and to ride out market fluctuations. The company does not pay a dividend, so returns will depend on capital appreciation.